EHF Antikörper (C-Term)
Kurzübersicht für EHF Antikörper (C-Term) (ABIN6952395)
Target
Alle EHF Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- C-Term
-
Spezifität
- Polyclonal antibody raised in rabbit against human EHF (ETS Homologous Factor), using two synthetic peptides containing a sequence from the central part and the C-terminus of the protein, respectively.
-
Aufreinigung
- Peptide affinity purified
-
Immunogen
- synthetic peptide
-
-
-
-
Applikationshinweise
-
ChIP/ChIP-seq 1 - 2 μg:ChIP
ELISA 1:1,000 - 1:50,000
WB not recommended -
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 1.1 μg/μL
-
Buffer
- PBS, 0.05 % azide
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
-
- EHF (Ets Homologous Factor (EHF))
-
Andere Bezeichnung
- EHF
-
Hintergrund
- EHF (UniProtKB/Swiss-Prot entry Q9NZC4) belongs to the ETS transcription factor family. This transcriptional activator shows epithelial-specific expression and plays a role in regulating epithelial cell differentiation and proliferation. EHF may also act as a transcriptional repressor of a specific subset of ETS/AP-1-responsive genes and as a modulator of the nuclear response to mitogen-activated protein kinase signaling cascades. EHF is also a putative tumor suppressor gene and may be involved in carcinogenesis.
-
UniProt
- Q9NZC4
Target
-